ShareValue scores for 0314.HK: Valuation 62, Quality 36, Growth 35, Health 55.

0314.HK
HKEX

Sipai Health Technology Co. Ltd.

HK$1.48(+10.04%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
62
Fair Value
Price vs Value
Quality
36
Weak
Business Strength
Growth
35
Weak
Revenue & Earnings
Health
55
Moderate
Financial Stability
Momentum
47
Neutral
Price Trend

Company Details

About

Sipai Health Technology Co., Ltd., together with its subsidiaries, operates as a medical technology and health management company in the People's Republic of China. It operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Commercial Insurance Services Business. The company operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. It also provides site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and other services to pharmaceutical companies and other clinical trial institutions; and services for image management in clinical trials. In addition, the company offers insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. Further, it is involved in retail of pharmaceutical products; and provision of pharmacist and physician research assistance services. The company was founded in 2014 and is based in Shanghai, the People's Republic of China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026